Watch for Action: AAR Corp. (NYSE:AIR), Aflac Incorporated (NYSE:AFL), NVIDIA Corporation (NASDAQ:NVDA), Merck & Co. Inc. (NYSE:MRK), Cubic Corporation (NYSE:CUB)

Posted by on Jan 05, 2016

AAR Corp. (NYSE:AIR) shares moved down -1.90% in last trading session and ended the day at $25.79. AIR Gross Margin is 9.00% and its has a return on assets of 1.10%. AAR Corp. (NYSE:AIR) quarterly performance is 27.46%.

AAR Corp. (NYSE:AIR) had its price objective lifted by Credit Suisse from $23.00 to $25.00 in a report released on Tuesday morning, Marketbeat reports. They currently have a neutral rating on the stock.

Aflac Incorporated (NYSE:AFL) ended the last trading day at $59.18. Company weekly volatility is calculated as 1.20% and price to cash ratio as 7.17. Aflac Incorporated (NYSE:AFL) showed a weekly performance of -1.66%.

On 28 December, Aflac Incorporated (NYSE:AFL) said that, in support of its sponsorship of the Heisman Trophy, is launching a series of four online videos with Heisman Trophy Winner Herschel Walker.

On 04 January, NVIDIA Corporation (NASDAQ:NVDA) shares moved down -1.79% and was closed at $32.37. NVDA EPS growth in last 5 year was 62.50%. NVIDIA Corporation (NASDAQ:NVDA) year to date (YTD) performance is -1.79%.

On 31 December, NVIDIA Corporation (NASDAQ:NVDA) announced its next graphics architecture dubbed Pascal back in March 2015. In November, the company revealed that its next generation of graphics cards will boast higher bandwidth memory resulting in improved memory speed for better graphics performance, according to a report in Digital Trends.

Merck & Co. Inc. (NYSE:MRK) shares moved down -0.64% in last trading session and ended the day at $52.48. MRK Gross Margin is 63.70% and its has a return on assets of 10.50%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is 5.57%.

Merck & Co. Inc. (NYSE:MRK) said that, Privately held Syndax Pharmaceuticals is pairing its breakthrough-designated cancer drug with an in-development immunotherapy from Merck KGaA and Pfizer ($PFE), hoping to hit upon a winning clinical combination.

Cubic Corporation (NYSE:CUB) ended the last trading day at $47.40. Company weekly volatility is calculated as 1.92% and price to cash ratio as 5.12. Cubic Corporation (NYSE:CUB) showed a weekly performance of 0.34%.

On 23 December, Cubic Corporation (NYSE:CUB) announced the acquisition of TeraLogics, LLC and the signing of a definitive agreement to acquire GATR Technologies, Inc. (GATR). The addition of TeraLogics and GATR will enhance Cubic’s stated strategy to expand its defense systems business by investing in a Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance (C4ISR) portfolio focused on secure and expeditionary communications, and ISR Processing, Exploitation and Dissemination (PED).

Leave a Reply

Your email address will not be published. Required fields are marked *